CHINATRIALS+US brings together 100+ senior clinical development executives from Chinese innovative biotechs interested in conducting clinical trials in the US and US biotechs who have interest conducting clinical trials in or entering the China market.
The focus of discussion will be on the strategic and technical considerations these companies should consider when entering the US or China markets. We hope the synergies of bringing these two important groups together will introduce new opportunities for partnerships and collaborations for parallel drug development in the US and China.
BioPharma R&D Company Rate
$1,295 USD / 9,200 CNY Early Bird Rate by May 3, 2019 ($1,595 USD / 11,300 CNY after May 3, 2019)
If your company has a drug or device in preclinical/clinical development, or a product already on the market, you are eligible for the R&D rate.
BioPharma R&D Company Group Rates*
*If you are an R&D Company and your team is interested in sending multiple attendees, please email us at firstname.lastname@example.org to register as a group. The group discounts are listed below.
Group Rate (2 or more attendees): $1,000 USD / 7,000 CNY per attendee
$1,495 USD / 10,500 CNY Early Bird Rate by May 3, 2019 ($1,895 USD / 13,500 CNY after May 3, 2019)
If you are not eligible for the R&D Rate option listed above, you must select Standard Rate when registering.
团体价（2 人以上参会者）：1,000美金/ 7,000 人民币每人